RARE - Ultragenyx Pharmaceutical Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$51.38
DETAILS
HIGH:
$83.00
LOW:
$30.00
MEDIAN:
$44.50
CONSENSUS:
$51.38
UPSIDE:
99.77%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-08-03 | Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | SELL | 1,900 | $24.92 | $47K |
| 2026-08-03 | Horn Howard | officer: Chief Financial Officer | SELL | 4,696 | $24.92 | $117K |
| 2026-07-01 | Horn Howard | officer: Chief Financial Officer | SELL | 4,698 | $33.13 | $156K |
| 2026-06-15 | Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | SELL | 1,899 | $24.62 | $47K |
| 2026-06-15 | Sanders Corazon (Corsee) D. | director | SELL | 2,000 | $25.05 | $50K |
| 2026-06-01 | Horn Howard | officer: Chief Financial Officer | SELL | 4,653 | $23.77 | $111K |
| 2026-05-14 | Sanders Corazon (Corsee) D. | director | A-Award | 7,751 | -- | -- |
| 2026-05-14 | Sanders Corazon (Corsee) D. | director | A-Award | 14,058 | $25.80 | $363K |
| 2026-05-14 | Fust Matthew K | director | A-Award | 7,751 | -- | -- |
| 2026-05-14 | Fust Matthew K | director | A-Award | 14,058 | $25.80 | $363K |
| 2026-05-14 | WELCH DANIEL G | director | A-Award | 7,751 | -- | -- |
| 2026-05-14 | Ray Amrit | director | A-Award | 7,751 | -- | -- |
| 2026-05-14 | WELCH DANIEL G | director | A-Award | 14,058 | $25.80 | $363K |
| 2026-05-14 | NARACHI MICHAEL | director | A-Award | 7,751 | -- | -- |
| 2026-05-14 | NARACHI MICHAEL | director | A-Award | 14,058 | $25.80 | $363K |
| 2026-05-14 | Dunsire Deborah | director | A-Award | 7,751 | -- | -- |
| 2026-05-14 | Dunsire Deborah | director | A-Award | 14,058 | $25.80 | $363K |
| 2026-05-14 | SULIMAN SHEHNAAZ | director | A-Award | 7,751 | -- | -- |
| 2026-05-18 | SULIMAN SHEHNAAZ | director | SELL | 5,740 | $25.12 | $144K |
| 2026-05-14 | SULIMAN SHEHNAAZ | director | A-Award | 14,058 | $25.80 | $363K |
| 2026-05-14 | Ray Amrit | director | A-Award | 14,058 | $25.80 | $363K |
| 2026-05-05 | Crombez Eric | officer: EVP and Chief Medical Officer | SELL | 344 | $24.96 | $9K |
| 2026-05-01 | Horn Howard | officer: Chief Financial Officer | SELL | 4,683 | $24.90 | $117K |
| 2026-04-22 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | A-Award | 7,348 | $24.61 | $181K |
| 2026-04-22 | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | A-Award | 20,241 | -- | -- |